Clal Biotechnology Industries Dividends and Buybacks
Dividend criteria checks 0/6
Clal Biotechnology Industries does not currently pay a dividend.
Key information
0%
Dividend yield
n/a
Buyback Yield
| Total Shareholder Yield | n/a |
| Future Dividend Yield | n/a |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | ₪0.220 |
| Payout ratio | 0% |
Recent dividend and buyback updates
No updates
Recent updates
Clal Biotechnology Industries (TLV:CBI) Is Carrying A Fair Bit Of Debt
Oct 09
The Market Doesn't Like What It Sees From Clal Biotechnology Industries Ltd.'s (TLV:CBI) Revenues Yet
Apr 18Calculating The Fair Value Of Clal Biotechnology Industries Ltd. (TLV:CBI)
Jul 14Does Clal Biotechnology Industries (TLV:CBI) Have A Healthy Balance Sheet?
Jan 19Investors Shouldn't Be Too Comfortable With Clal Biotechnology Industries' (TLV:CBI) Robust Earnings
Mar 25Clal Biotechnology Industries (TLV:CBI) Seems To Use Debt Quite Sensibly
Mar 24Introducing Clal Biotechnology Industries (TLV:CBI), The Stock That Zoomed 121% In The Last Year
Feb 16
What Kind Of Shareholders Own Clal Biotechnology Industries Ltd. (TLV:CBI)?
Jan 12Is Clal Biotechnology Industries (TLV:CBI) Using Too Much Debt?
Dec 07Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if CBI's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if CBI's dividend payments have been increasing.
Dividend Yield vs Market
| Clal Biotechnology Industries Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (CBI) | 0% |
| Market Bottom 25% (IL) | 2.2% |
| Market Top 25% (IL) | 5.9% |
| Industry Average (Biotechs) | 1.1% |
| Analyst forecast (CBI) (up to 3 years) | n/a |
Notable Dividend: Unable to evaluate CBI's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate CBI's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: CBI is not paying a notable dividend for the IL market.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as CBI has not reported any payouts.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/19 06:36 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Clal Biotechnology Industries Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Pravin Gondhale | Virtua Research Inc. |